通过共价捕获延长GLP-1受体的激活
Özge Ünsal1, Z Selin Bacaksiz1, Vladislav Khamraev1
1Department of Chemistry, Tufts University, Medford, Massachusetts 02155, United States.
ACS chemical biology
|June 27, 2024
概括
研究人员设计了一种新型的葡萄糖类-1 (GLP-1) 模拟物,该模拟物与GLP-1受体 (GLP-1R) 共同结合. 这种修改显著延长受体激活,为开发更有效的代谢性疾病治疗提供了有希望的策略.
科学领域:
- 内分泌学和新陈代谢学
- 药用化学 医学化学
- 分子药理学分子药理学
背景情况:
- 类似葡萄糖-1 (GLP-1) 是一种关键的肠道激素,调节葡萄糖平衡,促进体重减轻.
- 原生GLP-1的半衰期在体内很短,限制了其治疗潜力.
- GLP-1受体 (GLP-1R) 激进作用是GLP-1及其衍生物的有益代谢作用的基础.
研究的目的:
- 设计和开发长寿命的GLP-1受体激动剂.
- 为了研究共价交叉链接对长时间GLP-1R激活的潜力.
主要方法:
- 类同类的结构导向设计,包括用于共价捕获的电友性弹头.
- 使用洗实验对化合物的评估,以评估耐药性和长时间激活.
- 加入三乙烯基组以保护蛋白酶和C18二酸性脂质作为延伸剂.
主要成果:
- 具有共价交联能力的类类似物显示出显著增加的冲洗耐药性,表明GLP-1R的长时间激活.
- 添加一个SulF可交叉链接的弹头,N-终端三乙基和C18二酸脂的添加增强了GLP-1的洗阻力.
- 该化合物C2K26DAC18_K34SulF,具有所有三种修饰,表现出最强大和最长寿命的GLP-1R激素.
结论:
- 对GLP-1类似物进行共价修饰可以实现持续的GLP-1R激活,克服原生GLP-1短半衰期的局限性.
- 开发的化合物C2K26DAC18_K34SulF作为设计临床可行的长效GLP-1R激动剂的概念验证.
- 这一战略对开发用于代谢障碍的新疗法具有前景.
相关概念视频
Glucagon-like Receptor Agonists
313
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
313
GPCRs Regulate Adenylyl Cylase Activity
5.5K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.5K
GPCR Desensitization
5.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.9K
cAMP-dependent Protein Kinase Pathways
6.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.3K
Insulin Secretory Vesicles
4.9K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.9K
Receptor-mediated Endocytosis
104.3K
Overview
104.3K


